Pharming Group (PHAR) has appointed Chief Commercial Officer Leverne Marsh and Chief Financial Officer Kenneth Lynard as interim co-chief executive officers, the company said Tuesday.
The two will succeed Fabrice Chouraqui, who has stepped down from the role.
The company said it has begun a search process for a permanent CEO.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.